Noxilizer
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $775k | Debt | |
N/A | $2.1m | Debt | |
N/A | $3.6m | Debt | |
N/A | Growth Equity VC | ||
Total Funding | - |
Recent News about Noxilizer
EditNoxilizer specializes in providing advanced sterilization solutions using proprietary Nitrogen Dioxide (NO2) technology. The company caters to pharmaceutical, biotech, and medical device manufacturers, offering both sterilization equipment and contract sterilization services. Operating in the healthcare and life sciences market, Noxilizer's business model revolves around selling its unique NO2 sterilization equipment and providing ongoing sterilization services. This dual approach allows the company to generate revenue from both product sales and service contracts. Noxilizer's technology is particularly effective for sterilizing polymer-based prefilled syringes, ensuring drug integrity and minimizing the risk of adverse effects. The company also boasts a team of expert microbiologists and material compatibility specialists who collaborate with clients to address complex sterilization challenges.
Keywords: Nitrogen Dioxide, sterilization, pharmaceutical, biotech, medical devices, prefilled syringes, contract services, healthcare, life sciences, microbiology.